- Home
- DHT vs VRDN Comparison
DHT vs VRDN Comparison
Compare DHT & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHT
- VRDN
- Stock Information
- Founded
- DHT 2005
- VRDN 2006
- Country
- DHT Bermuda
- VRDN United States
- Employees
- DHT N/A
- VRDN N/A
- Industry
- DHT Marine Transportation
- VRDN Medical Specialities
- Sector
- DHT Consumer Discretionary
- VRDN Health Care
- Exchange
- DHT Nasdaq
- VRDN Nasdaq
- Market Cap
- DHT 1.7B
- VRDN 1.5B
- IPO Year
- DHT 2005
- VRDN N/A
- Fundamental
- Price
- DHT $10.76
- VRDN $18.13
- Analyst Decision
- DHT Strong Buy
- VRDN Buy
- Analyst Count
- DHT 4
- VRDN 12
- Target Price
- DHT $14.50
- VRDN $36.44
- AVG Volume (30 Days)
- DHT 1.7M
- VRDN 1.6M
- Earning Date
- DHT 02-04-2025
- VRDN 02-25-2025
- Dividend Yield
- DHT 9.29%
- VRDN N/A
- EPS Growth
- DHT N/A
- VRDN N/A
- EPS
- DHT 1.00
- VRDN N/A
- Revenue
- DHT $583,758,000.00
- VRDN $302,000.00
- Revenue This Year
- DHT N/A
- VRDN $2.55
- Revenue Next Year
- DHT $5.02
- VRDN N/A
- P/E Ratio
- DHT $10.76
- VRDN N/A
- Revenue Growth
- DHT N/A
- VRDN N/A
- 52 Week Low
- DHT $8.67
- VRDN $11.40
- 52 Week High
- DHT $12.80
- VRDN $27.20
- Technical
- Relative Strength Index (RSI)
- DHT 61.48
- VRDN 44.39
- Support Level
- DHT $10.79
- VRDN $16.60
- Resistance Level
- DHT $11.41
- VRDN $21.58
- Average True Range (ATR)
- DHT 0.34
- VRDN 1.00
- MACD
- DHT 0.19
- VRDN -0.16
- Stochastic Oscillator
- DHT 72.34
- VRDN 30.72
About DHT DHT Holdings Inc.
DHT Holdings Inc is a crude oil tanker company. It is an independent crude oil tanker company. Its fleet trades internationally and consists of crude oil tankers in the VLCC. It generates revenues from time charter and spot market operations. Its fleets consist of very large crude carriers known as VLCCs that range in size from 270,000 to 320,000 deadweight tons. Geographically, DHT operates in Monaco, Oslo, Norway, and Singapore. The company generates the majority of its revenue from the shipping revenues.
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.